WebApr 14, 2024 · A variety of pathogenic inactivating alterations were observed in TSC1 and TSC2 genes, though TSC2 mutations were most commonly frameshift mutations; no recurring mutations were observed. A tumor-agnostic study (PRECISION 1: NCT05103358) is now recruiting patients with pathogenic inactivating TSC1 or TSC2 alterations to further … WebApr 14, 2024 · Phase III Abstracts presenting at AACR 2024. Drawing attention to the Phase II data readout, we have cancer vaccine players Moderna and Transgene excited about …
TSC1 gene: MedlinePlus Genetics
WebFeb 1, 2011 · Overview of the TSC1 and TSC2 variants analyzed as part of this study. Amino acid variants are numbered as originally described [van Slegtenhorst et al., 1997; European Chromosome 16 Tuberous Sclerosis Consortium, 1993] (GenBank AF013168.1; GI: 2331280 [TSC1] and X75621; GI:450351 [TSC2]) and according to the amino acid sequences … WebJan 20, 2024 · TSC is caused by genetic mutations on either the TSC1 or TSC2 gene. Only one of the genes needs to be affected for TSC to be present. A mutation of either one of these genes leads to abnormal development and exponential growth of cells within the body. The TSC1 gene produces a protein called hamartin. The TSC2 gene produces the protein … grant application writer\\u0027s workbook
Iyer Shares Ongoing Research in TSC1/2-Mutant Genitourinary …
WebIn TSC1/2-altered patients, 58.5% were male, 47.6% were at advanced stage (stage III or IV) and the median age was 61 years old (range, 29-81 years old). In TSC1 altered cases, the median TMB was 4.7 muts/Mb, ranging from 0 to 88.3 muts/Mb. In TSC2 altered cases, the median TMB was 7.7 muts/Mb, ranging from 0 to 128.7 muts/Mb. WebMar 30, 2005 · The ratio of TSC2:TSC1 mutations was 3.4:1. In our cohort, both TSC1 mutations and mutations in familial TSC2 cases were associated with phenotypes less … WebApr 23, 2024 · Inactivating mutations in either TSC1 or TSC2 cause Tuberous Sclerosis Complex, an autosomal dominant disorder, characterized by multi-system tumor and hamartoma development. Mutation and loss of function of TSC1 and/or TSC2 also occur in a variety of sporadic cancers, and rapamycin and related drugs show highly variable … grant approval contact number